trending Market Intelligence /marketintelligence/en/news-insights/trending/SigwKEgl2ege2eiERfNaVw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Pfizer to sell Colo. facility to CordenPharma

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Pfizer to sell Colo. facility to CordenPharma

Pfizer Inc. is selling its former Hospira Boulder active pharmaceutical ingredients site in Colorado to CordenPharma, a contract development and manufacturing organization.

CordenPharma will also enter into a multiyear supply arrangement with Pfizer.

Hospira Boulder will change its name to CordenPharma Boulder and will be managed by Brian McCudden, CEO of CordenPharma Colorado.

The transaction is expected to close in November.